ELDON BIOLOGICALS A/S: Financial statements 2017
CVR: 26747007
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
ELDON BIOLOGICALS A/S (CVR 26747007) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 7,982,628 and a net result of DKK 2,615,616 compared with DKK 1,219,431 the year before. That is an increase of 31.4% compared with the year before. Equity in the 2017 report amounted to DKK 3,887,239. The solvency ratio was 41.1%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 7,982,628
- Profit/Loss
- DKK 2,615,616
- Equity
- DKK 3,887,239
- Total Assets
- DKK 9,465,714
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 8 mio. | 2.6 mio. | 3.9 mio. | 7 |
| 2016 | - | 6.1 mio. | 1.2 mio. | 1.3 mio. | - |
| 2015 | - | 6.1 mio. | 1.5 mio. | 319 t. | - |
| 2014 | - | 4.9 mio. | 1.1 mio. | -1.2 mio. | - |
| 2013 | - | 4.1 mio. | 949 t. | -2.3 mio. | - |
Keep an eye on ELDON BIOLOGICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout ELDON BIOLOGICALS A/S
ELDON BIOLOGICALS A/S is a Danish company of the type Aktieselskab based in Gentofte, founded in 2002. The company is registered under the industry Fremstilling af andre kemiske produkter i.a.n.. The management consists of Kasper Juul Hedegaard. The board consists of Michael Lützhøft Hansen (chair), Cara Beth Seiderman and Kasper Juul Hedegaard. The company is owned by MEDI-TRADE ApS and HOLDINGSELSKABET MLH ApS. The company has 9 employees (2018). In 2025, the company reported a gross profit of DKK 13,635,058 and a net result of DKK 3,900,353 compared with DKK 6,673,643 the year before. Equity in the 2025 report amounted to DKK 42,055,949.